Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 0 | 0 | 0 | 0 | 49,478 |
| Gross Profit | N/A | N/A | N/A | N/A | 49,478 |
| Operating Expenses | 17,459 | 13,265 | 12,686 | 13,350 | 16,534 |
| Operating Income | -16,537 | -13,265 | -12,686 | -13,350 | 32,944 |
| Interest Expense | 56 | 66 | 55 | 83 | 124 |
| Other Income | 366 | -2,026 | 1,426 | 257 | 137 |
| Pre-tax Income | -16,227 | -15,357 | -11,315 | -13,176 | 32,957 |
| Net Income Continuous | -15,088 | -15,357 | -11,315 | -13,176 | 32,957 |
| Net Income | $-15,088 | $-15,357 | $-11,315 | $-13,176 | $32,957 |
| EPS Basic Total Ops | -0.47 | -0.56 | -0.41 | -0.54 | 1.45 |
| EPS Basic Continuous Ops | -0.47 | -0.56 | -0.41 | -0.54 | 1.46 |
| EPS Diluted Total Ops | -0.47 | -0.56 | -0.41 | -0.54 | 1.45 |
| EPS Diluted Continuous Ops | -0.47 | -0.56 | -0.41 | -0.54 | 1.46 |
| EBITDA(a) | $-16,978 | $-12,754 | $-12,156 | $-12,814 | $33,491 |